TOKAI (9729) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
11 Nov, 2025Executive summary
Consolidated net sales increased for the fifth consecutive year, reaching ¥79,026 million for the six months ended September 30, 2025, up 8.7% year-over-year, with operating profit up 21.1% to ¥4,436 million and ordinary profit up 20.0% to ¥4,699 million.
Profit attributable to owners of parent was ¥3,048 million, nearly flat year-over-year, while comprehensive income surged 71.6% to ¥3,954 million.
Growth was driven by strong performance in core rental, cleaning equipment manufacturing, and dispensing pharmacy businesses, as well as contributions from newly consolidated subsidiaries.
Financial highlights
Gross profit increased to ¥19,023 million from ¥16,990 million year-over-year, with selling, general and administrative expenses rising to ¥14,587 million.
Basic earnings per share for the period was ¥90.13, up from ¥88.82 in the prior year.
Total assets as of September 30, 2025, were ¥116,992 million, with net assets at ¥88,872 million and an equity-to-asset ratio of 75.4%.
Equity ratio improved to 75.4% from 74.8% sequentially.
Outlook and guidance
Full-year forecast for the fiscal year ending March 31, 2026, projects net sales of ¥157,976 million (up 5.6% year-over-year), operating profit of ¥8,216 million, and profit attributable to owners of parent of ¥5,499 million (up 16.2%).
Basic earnings per share for the full year is forecast at ¥162.69.
Aims for a cumulative total payout ratio of 70% or higher under the three-year medium-term management plan (FY3/26–FY3/28).
Forecasts include commemorative dividends for the 70th anniversary and continued stable dividends.
Latest events from TOKAI
- Record sales and profit growth, driven by rental, pharmacy, M&A, and special dividends.9729
Q3 202612 Feb 2026 - Record sales and operating profit, but net profit fell; outlook and dividend raised.9729
Q1 20267 Aug 2025 - Net sales and net income increased, but full-year profit is forecast to decline.9729
Q2 202513 Jun 2025 - Sales and profits rose, with strong Q1 gains and stable full-year outlook.9729
Q1 202513 Jun 2025 - Record sales and profit growth, but net income fell on impairments; outlook remains positive.9729
Q4 20256 Jun 2025 - Record sales growth, but profit pressured by higher costs and securities losses.9729
Q3 20255 Jun 2025